Not yet recruitingNCT06993584

Pharmacokinetic Modelling of Levosimendan in Adults

Studying Cardiogenic shock

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital, Rouen
Principal Investigator: Thomas TD DUFLOT, PharmD
pharmacology department, University Hospital of Rouen
Intervention: Adult patients in cardiogenic shock(other)
Enrollment: 100 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2025 – 2027

Study locations (3)

Cardio-Thoracic-Vascular Resuscitation Department, university Hospital of Amiens, Amiens, France
Anesthesia Clinic - Resuscitation, University Hospital of Lile, Lille, France
Anesthesia-Resuscitation Department, University Rouen Hospital, Rouen, France

Collaborators

University Hospital, Lille · Amiens University Hospital, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06993584 on ClinicalTrials.gov

Other trials for Cardiogenic shock

Additional recruiting or active studies for the same condition.

See all trials for Cardiogenic shock →

← Back to all trials